Company: BIVIW
Filing Date: 2025-08-04
Form Type: S-1/A
Source: 0001520138-25-000235
Chunk: 110

Company: BIOVIE INC.
Filing Date: 2025-08-04
Form: S-1/A
Chunk 110
---
600,000 shares of Common Stock, and warrants to purchase up to 1,050,000
shares of Common Stock (the “Common Warrants”) (CUSIP 09074F132) at a combined public offering price of $10.00 per Share,
or Pre-funded Warrant, and the associated Common Warrant. The gross proceeds to the Company from the March 2024 Offering were approximately
$21 million, before deducting placement agent fees and offering expenses of approximately $2.5 million. Upon closing of the March 2024
Offering, the Company issued the placement agent a warrant (“Placement Agent’s Warrant”) to purchase 105,000 shares
of Common Stock exercisable at a per share price of $12.50, which was equal to 125% of the public offering price per Share. The Placement
Agent’s Warrant is exercisable during a five-year period commencing 180 days from March 6, 2024.

On September 25, 2024, the Company closed a best
efforts public offering (the “September 2024 Offering”) of 1,360,800 shares of its common stock, par value $0.0001 per share,
pre-funded warrants (the “September Pre-funded Warrants”) to purchase 600,000 shares of Common Stock, and warrants to purchase
up to 1,960,800 shares of Common Stock (the “September Common Warrants”) at a combined public offering price of $1.53 per
Share, or September Pre-funded Warrant, and the associated September Common Warrant. 265,000 September Pre-funded Warrants were exercised
in the three months ended September 30, 2024 and reflected on the condensed statement of changes in stockholders’ equity as a component
of proceeds from issuance of common stock. The September Common Warrants have an exercise price of $1.53 per share and are immediately
exercisable upon issuance and will expire on the fifth anniversary date of the original issuance date. The gross proceeds to the
Company from the September 2024 Offering were approximately $3.0 million, before deducting placement agent fees and offering expenses
of approximately $747,000. Additionally, upon closing, the Company issued the placement agent warrants (“September Placement Agent’s
Warrants”) to purchase 98,040 shares of Common Stock exercisable at a per share price of $1.91, which was equal to 125% of the public
off